Document 0654
 DOCN  M9440654
 TI    [The combined immunoenzyme test: anti-HIV-1 and -2 and anti-HTLV-1 in
       the detection of donors with retrovirus infections]
 DT    9404
 AU    Dobec M; Jung M; Zupancic-Salek S; Burek V; Mihaljevic I; Grgicevic D;
       Institut Virion, Zurich, Svicarska.
 SO    Lijec Vjesn. 1993 May-Jun;115(5-6):142-5. Unique Identifier : AIDSLINE
       MED/94133863
 AB    Serums of whole blood donors, plasma donors, hemophiliacs, persons with
       risks behavior and normal population simultaneously were tested for
       markers of infectious diseases, anti-HIV-1 with Plivazim and
       anti-HIV-1/2 and anti-HTLV-1/2 with Roche Retrovirus EIA. The positive
       results were confirmed by immunofluorescence assay and Western blot.
       Nonspecific reactive serums were detected by Roche Retrovirus EIA and by
       Plivazim EIA, but there was no significant difference in the frequence
       of reactive results. Roche Retrovirus EIA test had specificity of 99.16%
       and sensibility of 97.56% as compared to Plivazim. Simultaneous testing
       of donors with a combined test for anti-HIV-1/2 and anti-HTLV-1 is
       equally reliable as testing with only anti-HIV-1.
 DE    *AIDS Serodiagnosis  *Blood Donors  English Abstract
       Hemophilia/IMMUNOLOGY  Human  HIV Antibodies/*ANALYSIS  HTLV-I
       Antibodies/*ANALYSIS  *Immunoenzyme Techniques  Sensitivity and
       Specificity  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).